IFI27 and pancreatic neoplasm: IFI27 (Interferon Alpha Inducible Protein 27) has been proposed as a potential prognostic biomarker in pancreatic cancer, where its overexpression correlates with increased cell proliferation, metastasis, and malignant progression [11].